Dr. Wollner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2799 West Grand Boulevard
CFP 579
Detroit, MI 48202Phone+1 313-916-1332Fax+1 313-916-7911
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 1983 - 1985
- University of Michigan Health SystemFellowship, Geriatric Medicine (Internal Medicine), 1982 - 1983
- University of MichiganResidency, Internal Medicine, 1979 - 1982
- Rutgers New Jersey Medical SchoolClass of 1979
Certifications & Licensure
- MI State Medical License 1980 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
Publications & Presentations
PubMed
- Treatment of unresectable and resectable stage IV colorectal cancer.Julia L Bachler, Gazala N Khan, Ira S Wollner, Philip A Philip
Clinical Advances in Hematology & Oncology. 2024-11-01 - 57 citationsPhase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.Julie R Brahmer, Charles G Drake, Ira Wollner, John D Powderly, Joel Picus
Journal of Clinical Oncology. 2023-02-01 - 8 citationsNeoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic CancerKannan Thanikachalam, Vijay Damarla, Trevor Seixas, Irina Dobrosotskaya, Ira Wollner
American Journal of Clinical Oncology. 2020-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: